Immune to Cancer: The CRI Blog
-
Third Immunotherapy Option Approved for Bladder Cancer Patients
On February 2, nivolumab (Opdivo®, Bristol-Myers Squibb) became the newest FDA-approved immunotherapy available for patients with bladder…
-
Immunotherapy Shows Promise Against Previously Untreatable Stomach Cancer
Nivolumab improves survival in patients with advanced stomach cancer.
-
Focused Ultrasound Foundation to Host Free Webinar on Recent Advances in Cancer Immunotherapy
CRI’s CEO and director of scientific affairs will discuss latest research on focused ultrasound and immunotherapy combination…
-
2016: The Year of Cancer Immunotherapy
New immunotherapy approvals, “Advance of the Year” recognition, and the partnerships of the future.
-
Remembering Six-Time Jeopardy! Champion Cindy Stowell
Cindy, who passed from stage 4 colon cancer, has donated her winnings to the Cancer Research Institute.
-
Young Adults “Chasing Cancer”
Guest blogger Ariella Chivil recaps her visit at The Washington Post Chasing Cancer Summit.
-
Immuno-Oncology 360°: Connecting Science & Business to Advance Immunotherapy
The third annual IO360° conferences comes to NYC February 2017.
-
Remembering Renowned Immunology Pioneer Georg Klein
The longtime member of CRI’s Scientific Advisory Council sought to save lives through research and education.
-
ASH 2016: Tackling Blood Cancers with Immunotherapy
The largest meeting focused on blood cancers begins December 3 in San Diego.
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.